Author Archives: JmaC

The U.S. Food and Drug Administration today approved Belsomra (suvorexant) tablets for use as needed to treat difficulty in falling and staying asleep (insomnia). Belsomra is an orexin receptor antagonist and is the first approved drug of this type. Orexins … Continue reading →

Researchers at NYU Langone Medical Center and elsewhere, using a mouse model, have recorded the activity of individual nerve cells in a small part of the brain that works as a “switchboard,” directing signals coming from the outside world or … Continue reading →

People with schizophrenia struggle to turn goals into actions because brain structures governing desire and emotion are less active and fail to pass goal-directed messages to cortical regions affecting human decision-making, new research reveals. Published in Biological Psychiatry, the finding … Continue reading →

Some working parents are carrying more psychological baggage than others – and the reason has nothing to do with demands on their time and energy. The cause is their occupation. According to University of Iowa researchers, parents who hold jobs … Continue reading →

More than 40 percent of Social Security Disability Insurance (SSDI) recipients take opioid pain relievers, while the prevalence of chronic opioid use is over 20 percent and rising, reports a study in the September issue of Medical Care. The journal … Continue reading →